Polysaccharide microparticles as an oral vaccine platform: proof-of-concept in male rats using a GnRH-targeting fusion antigen - Summary - MDSpire

Polysaccharide microparticles as an oral vaccine platform: proof-of-concept in male rats using a GnRH-targeting fusion antigen

  • By

  • Maximiliano Wilda

  • Maria Victoria Rocca

  • M. Solana Pesca

  • Pablo Rafael Grigera

  • June 10, 2026

  • 0 min

Share

Objective:

To evaluate whether alginate-chitosan microparticles entrapping a recombinant GnRH-fusion protein (GF45) can elicit an immunocastrating response in male rats after oral administration.

Key Findings:
  • statistical_significance
Interpretation:

Remove unsupported conclusions or attribute them to the source.

Limitations:
  • Add any limitations mentioned in the source.
Conclusion:

Remove unsupported claims about potential applications or attribute them.

Original Source(s)

Polysaccharide microparticles as an oral vaccine platform: proof-of-concept in male rats using a GnRH-targeting fusion antigen

  • by Maximiliano Wilda, Maria Victoria Rocca, M. Solana Pesca, Pablo Rafael Grigera

  • June 10, 2026

Related Content

Vitamin D supports activated CD4+ T-cell proliferation through enhanced glutaminolysis

Cobalt nanoparticles protect against endocrine disruption in response to multiple abiotic stresses in fish

Brain alteration of PCOS: neuroimaging and function